Walvax Biotechnology Co., Ltd.

Chinese vaccine maker focused on pneumococcal, HPV and meningococcal vaccines

What Walvax Biotechnology does

Walvax develops, makes and sells vaccines that protect against infectious diseases such as pneumonia, meningitis, cervical-cancer-causing HPV, and whooping cough. It sells mainly in China and also internationally. The company was founded in 2001 and is based in Kunming.

How Walvax Biotechnology makes money

It earns revenue by manufacturing vaccines and selling them to healthcare and immunization channels in China and abroad.

Products & services

• 13-valent pneumococcal conjugate vaccine
• 23-valent pneumococcal polysaccharide vaccine
• Recombinant HPV bivalent vaccine
• Meningococcal vaccines (ACYW135, A+C polysaccharide and conjugate)
• Hib (haemophilus influenzae type b) conjugate vaccine
• DTaP combined vaccine